Earnings Feed
Start Free
Home/Filings/4/0001209191-16-128276
4//SEC Filing

Adamas Pharmaceuticals Inc 4

Accession 0001209191-16-128276

CIK 0001328143operating
View on SEC.govCompany Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 6:03 PM ET

Size

9.2 KB

Accession

0001209191-16-128276

Insider Transaction Report

Form 4
Period: 2016-06-15
Adamas Pharmaceuticals IncADMS
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2016-06-15$1.88/sh+204,900$384,188→ 263,658 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-06-15−204,900→ 0 total
    Exercise: $1.88Exp: 2016-09-12→ Common Stock (204,900 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    390,792

  • Common Stock

    (indirect: By Trust)
    80,000

  • Common Stock

    (indirect: By Trust)
    80,000
Footnotes (1)
  • [F1]This option is fully vested and exercisable.

Documents

1 file

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001328143

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:03 PM ET
Size
9.2 KB
View on SEC.gov